薬物による脳損傷における腸内微生物の機能不全:メカニズムと治療的影響
Jinghui Zhai1, Yue Zhang2, Shuyue Ma2
1Department of Clinical Pharmacy, The First Hospital of Jilin University, Changchun, Jilin, China.
Frontiers in cell and developmental biology
|September 2, 2025
まとめ
薬物誘発性脳損傷 (DIBI) は腸内微生物の不均衡と関連しており,酸化ストレスと神経炎症を引き起こす. プロバイオティクスやプレバイオティクスで腸の健康を回復することは DIBIおよび関連する認知障害の治療に有望です
科学分野:
- 神経科学
- 微生物学
- 毒理学について
背景:
- 薬物による脳損傷 (DIBI) は,薬の毒性,相互作用,または誤用から生じる.
- DIBIはますます腸内微生物の不活性化と関連しており,腸内脳軸に影響を及ぼしています.
- 抗生物質や抗腫瘍薬のような特定の薬は 腸内不活性症や全身の炎症を悪化させます
研究 の 目的:
- DIBIと腸内微生物多様性を関連付けるメカニズムを解明する.
- DIBIに関連した気分障害における微生物代謝産物と神経伝達物質の役割を調査する.
- DIBIの微生物のバランスを回復する治療の可能性を評価する.
主な方法:
- DIBIと腸内微生物の相互作用に関する既存の文献のレビュー.
- 酸化ストレス,神経炎症,代謝機能障害を含む経路の分析
- バクテリアの転移と腸-脳軸に対する薬物効果の検討.
主要な成果:
- 腸の機能不全は 酸化ストレス,神経炎症,代謝機能障害によって DIBIを誘発します
- この不均衡は 血脳障壁の漏れや 神経細胞の喪失や 認知の欠陥につながるのです
- 微生物の代謝物質や神経伝達物質は 怪我後の不安やうつ病に寄与します
結論:
- 腸内微生物のバランスを回復することは DIBIの潜在的な治療戦略です.
- プロバイオティクス,プレバイオティクス,微生物移植などの介入は DIBI経路を緩和することができます.
- 腸-脳軸をターゲットにすることで 薬物による神経損傷の管理に 新しいアプローチが提供されます
関連する概念動画
The Blood-brain Barrier
48.6K
Overview
48.6K
Irritable Bowel Syndrome I: Introduction
369
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
369
Inflammatory Bowel Disease IV: Pharmacological Management
185
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
185
Role of Neurotransmitters in Memory
964
Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
964
Factors Influencing Drug Absorption: Disease States and Pharmacology
766
Multiple disease states can significantly influence the oral drug absorption process by affecting blood flow and the functionality of the gastrointestinal (GI) system. Various GI diseases, including conditions that alter GI motility, such as diarrhea, decreased acid secretions (achlorhydria), and infections, have been associated with reduced drug absorption.
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
766
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
201
Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
201


